Scholars Central

Conference abstractPublished 26 Jun 2017

Development of a Thermoreversible Tenofovir Nano Gel

Authors: Pradeep K. Karla, Ramesh Nagarwal, Muhammad J. Habib, Anne-Marie Ako-Adouno

Howard University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: HIV is primarily transmitted as a sexually transmitted disease. The objective of the study is to develop a buffered thermoreversible gel containing tenofovir (TFR) loaded copolymer poly(lactic-coglycolic acid (PLGA) nanoparticles for prolonged protection against human immunodeficiency virus (HIV) sexual transmission. Methodology & Theoretical Orientation: Optimized buffered formulation containing TFR loaded PLGA nanoparticles was in sol (solution) form at 2-8Ã?°C and converted to a gel matrix at âÂ?¥25Ã?°C. PLGA nanoparticles were prepared by two methods: (a) Solvent diffusion method and, (b) Emulsification solvent evaporation. The particle size was measured using dynamic light scattering (DLS). Morphology of the particles was analysed by scanning electron microscope (SEM). Cytotoxicity of formulation components was evaluated using 24 hr 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium, inner salt (MTS) assay performed on human vaginal epithelial cells (VK2/E6E7). In vitro release of TFR from buffered thermoreversible nano gel containing PLGA nanoparticles was performed in simulated vaginal fluid (pH ~4.2) in a temperature controlled shaker equivalent to vaginal temperature ~34Ã?°C) at 60 rpm. Findings: The effective diameter range of nanoparticles prepared by both methods were 94.3-228 nm and 265-413 nm, respectively; micro image showed smooth and spherical shaped nanoparticles. Solvent diffusion method with a non-ionic surfactant (TritonÃ?® X-100) effectively reduced the particle size of nanoparticles but resulted in poor drug encapsulation. Emulsification solvent evaporation method resulted in improved drug encapsulation (1.43-10.78%) and drug loading values (0.25-1.18%) for nanoparticles. The formulation components were non cytotoxic from the 24 hr MTS assay performed on human vaginal epithelial cells. The formulation demonstrated a sustained drug release with a cumulative drug release of ~61% in 8 hrs and ~67.75% in 24 hrs. Drug release mechanism was diffusion controlled. Conclusion & Significance: Both preparation methods were found efficient to prepare PLGA nanoparticles. Results demonstrated a successful development and characterization of vaginal nano gel formulation for prolonged protection against HIV sexual transmission.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Pradeep K. Karla”
  • BylineArticles whose byline prints “Ramesh Nagarwal”
  • BylineArticles whose byline prints “Muhammad J. Habib”
  • BylineArticles whose byline prints “Anne-Marie Ako-Adouno”